Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets

André-Patrick Arrigo1, Stéphanie Simon, Benjamin Gibert

  • 1Laboratoire Stress, Chaperons et Mort Cellulaire, CNRS, UMR5534, Centre de Génétique Moléculaire et Cellulaire, Université Lyon 1, Bat. Gregor Mendel, 16 Rue Dubois, F-69622, Villeurbanne Cedex, France. arrigo@univ-lyon1.fr

FEBS Letters
|May 1, 2007
PubMed

Insights

Heat shock protein 27 (Hsp27) and alphaB-crystallin are chaperones with dual roles in disease. They protect cells but can also promote cancer, highlighting their complex implications in various pathologies.

Area of Science:

  • Molecular Biology
  • Cellular Stress Response
  • Pathology

Background:

  • Heat shock protein 27 (Hsp27) and alphaB-crystallin are constitutively expressed molecular chaperones.
  • These proteins protect cells against proteotoxicity, oxidative stress, and inflammation.
  • Both Hsp27 and alphaB-crystallin exhibit anti-apoptotic properties and can be tumorigenic in cancer cells.

Purpose of the Study:

  • To review current knowledge on Hsp27 and alphaB-crystallin.
  • To explore the implications of these chaperones in various diseases.
  • To present therapeutic strategies targeting Hsp27 and alphaB-crystallin.

Main Methods:

  • Literature review of existing research on Hsp27 and alphaB-crystallin.
  • Synthesis of information regarding their functions and roles in disease.
  • Analysis of therapeutic approaches for modulating chaperone activity.

Main Results:

  • Hsp27 and alphaB-crystallin have diverse protective functions.
  • These chaperones are implicated in neurodegenerative diseases, myopathies, asthma, cataracts, and cancers.
  • Their roles can be both beneficial and detrimental depending on the pathological context.

Conclusions:

  • Hsp27 and alphaB-crystallin are key players in cellular homeostasis and disease pathogenesis.
  • Modulating their expression or activity offers potential therapeutic avenues.
  • Further research is needed to fully elucidate their complex roles and optimize therapeutic strategies.